EVOME MEDICAL TECHNOLOGIES INC. Annual Net Cash Provided by (Used in) Financing Activities in CAD from 2020 to 2023

Taxonomy & unit
us-gaap: CAD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Evome Medical Technologies Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2020 to 2023.
  • Evome Medical Technologies Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was CA$2.58M, a 43.4% decline year-over-year.
  • Evome Medical Technologies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was CA$825K.
  • Evome Medical Technologies Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was CA$3.94M, a 27.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (CAD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 825K Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2021 3.94M -1.5M -27.5% Mar 1, 2021 Feb 28, 2022 10-KT 2023-04-03
2020 5.43M Mar 1, 2020 Feb 28, 2021 10-K 2022-05-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.